News
-
-
PRESS RELEASE
Positive Interim Venous Ulcer Healing Data Showing Significant Improvement from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented Today at the Society for Vascular Surgery 2024 Vascular Annual Meeting
Veno Medical Corporation presents positive interim data on VenoValve for venous ulcer healing at Society for Vascular Surgery meeting. Company aims for FDA approval in Q4 2024 -
-
PRESS RELEASE
New Interim Venous Ulcer Healing Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the Society for Vascular Surgery 2024 Vascular Annual Meeting on June 21, 2024
enVVeno Medical Corporation to present new interim venous ulcer healing data from VenoValve U.S. trial at VAM2024. Study focuses on treatment of venous disease with innovative bioprosthetic solutions -
-
PRESS RELEASE
enVVeno Medical Reports First Quarter 2024 Financial Results and Provides Corporate Update
enVVeno Medical Corporation reported ending the quarter with $42.9 million cash and investments to fund operations through 2025, presenting positive data at the 46th Annual Charing Cross Symposium -
-
PRESS RELEASE
Positive 11 Month Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical's VenoValve(R) Pivotal Trial to be Presented Today at the 46th Annual Charing Cross Symposium
enVVeno Medical presents positive efficacy data on VenoValve from SAVVE U.S. pivotal trial at Charing Cross International Symposium, showing clinical improvement for severe CVI patients -
-
PRESS RELEASE
New Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024
enVVeno Medical Corporation to present additional topline efficacy data from VenoValve U.S. pivotal trial at 2024 Charing Cross International Symposium in London. Data to review clinical status of severe Chronic Venous Insufficiency patients post VenoValve implantation
![Accesswire](/assets/images/accesswire-inline.png)
-
Cheech and Chong's Global Holding Company Takes a Stand in California Legislature
-
Aztec Samples 30.2m of 3.72 gpt Gold and 167.93 gpt Silver (5.82 gpt AuEq) from Ongoing 2024 Surface Exploration Program at Tombstone Gold-Silver Project, Arizona
-
Xcyte Digital Corp. Announces Closing of MCON Live Inc. Share Exchange and Asset Purchase
-
Terrance McCray Joins the Crestcom Network
-
Leveraging Twitter With Generative AI: Enhancing US Equity Investments
![EQS Group](/assets/images/eqs-group.png)
-
EQS-Adhoc: Flughafen Wien AG: Julian Jäger and Günther Ofner Reappointed to the Management Board of Flughafen Wien AG for a New Term of Office
-
COFICERT: COFICERT and Hédon Associés sign a strategic partnership for the deployment of the certification standard: ESG 1000
-
Form 8.3 - Lupus alpha Asset Management AG: Crest Nicholson Holdings Plc
-
Blue Cap AG: Annual General Meeting approves dividend of EUR 0.65 per share and appoints two new Supervisory Board members
-
EQS-Adhoc: Nakiki SE: Preliminary results for 2022 and 2023
![Les Echos](/assets/images/les-echos.png)
-
GUILLEMOT CORPORATION: Weekly report share buyback from June 17th 2024 to June 21st 2024
-
Statement of transactions in own shares from June 17, 2024 to June 19, 2024
-
Safran: exclusive discussions to acquire Preligens
-
PR – ICADE – Alexis de Nervaux is named Head of IT and Digital Transformation and joins Icade’s Executive Committee
-
Annual Results for 2023/2024